Sedky, Mohamed S <br/><br/>
Outcome of High-risk Langerhans Cell Histiocytosis (LCH) in Egyptian Children, Does Intermediate-dose Methotrexate Improve the Outcome?  [electronic resource] 

 -  Journal of pediatric hematology/oncology  11 2019 
 - 635-643 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1536-3678 
<br/><br/><label>Standard No.: </label>10.1097/MPH.0000000000001314  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Child<br/>Child, Preschool<br/>Disease-Free Survival<br/>Egypt--epidemiology<br/>Female<br/>Histiocytosis, Langerhans-Cell--drug therapy<br/>Humans<br/>Infant<br/>Male<br/>Methotrexate--administration & dosage<br/>Prohibitins<br/>Retrospective Studies<br/>Survival Rate